These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2825900)

  • 1. PAF-acether today--relevance for acute experimental anaphylaxis.
    Vargaftig BB; Braquet PG
    Br Med Bull; 1987 Apr; 43(2):312-35. PubMed ID: 2825900
    [No Abstract]   [Full Text] [Related]  

  • 2. PAF-acether and experimental anaphylaxis as a model for asthma.
    Pretolani M; Lellouch-Tubiana A; Lefort J; Bachelet M; Vargaftig BB
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):149-53. PubMed ID: 2540093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of (RS)-2-methoxy-3-(octadecylcarbamoyloxy)propyl 2-(3-thiazolio)ethyl phosphate, a specific PAF antagonist, in endotoxin and anaphylactic shock.
    Terashita Z; Imura Y; Nishikawa K; Sumida S
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():715-7. PubMed ID: 3004156
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of Ro 24-4736 in antagonizing the platelet and bronchoconstrictor responses to PAF.
    O'Donnell M
    Ann N Y Acad Sci; 1991; 629():416-8. PubMed ID: 1659287
    [No Abstract]   [Full Text] [Related]  

  • 5. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
    Baroggi N; Etienne A; Braquet P
    Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interrelationships among platelet-activating factor binding and metabolism and induction of platelet activation.
    Valone FH
    Prog Clin Biol Res; 1988; 283():319-40. PubMed ID: 2850575
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent development of platelet-activating factor antagonists.
    Shen TY; Hussaini I; Hwang SB; Chang MN
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():359-62. PubMed ID: 2546389
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet activating factor: a biologically active phosphoglyceride.
    Hanahan DJ
    Annu Rev Biochem; 1986; 55():483-509. PubMed ID: 3017194
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of analogs and antagonists of the thrombocyte-activating factor (PAF) on blood platelet aggregation].
    Lakin KM; Kulikov VI; Manevich EM; Muliar AG; Shvets VI
    Farmakol Toksikol; 1988; 51(4):113-23. PubMed ID: 2847936
    [No Abstract]   [Full Text] [Related]  

  • 10. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
    Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M
    Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.
    Tahraoui L; Floch A; Cavero I
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1221-7. PubMed ID: 2156995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor (PAF)--a putative mediator in inflammatory tissue injury.
    Yue TL; Rabinovici R; Feuerstein G
    Adv Exp Med Biol; 1991; 314():223-33. PubMed ID: 1667965
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of platelet agonists on the binding of platelet-activating factor to human platelets.
    Burgers JA; Akkerman JW
    J Lipid Mediat; 1992 Sep; 5(3):289-300. PubMed ID: 1334723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propenyl carboxamide derivatives as antagonists of platelet activating factor.
    Guthrie RW; Kaplan GL; Mennona FA; Tilley JW; Kierstead RW; O'Donnell M; Crowley H; Yaremko B; Welton AF
    J Med Chem; 1990 Oct; 33(10):2856-64. PubMed ID: 2170651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Platelet-activating factor (PAF) antagonists].
    Terasawa M
    Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):379-87. PubMed ID: 1850862
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet-activating factor binding to human platelet membranes.
    Valone FH; Ruis NM
    Biotechnol Appl Biochem; 1986 Oct; 8(5):465-70. PubMed ID: 3021183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships for platelet-activating factor (PAF) and analogues reveal differences between PAF receptors on platelets and macrophages.
    Stewart AG; Grigoriadis G
    J Lipid Mediat; 1991 Nov; 4(3):299-308. PubMed ID: 1662547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells.
    Korth R; Hirafuji M; Keraly CL; Delautier D; Bidault J; Benveniste J
    Br J Pharmacol; 1989 Oct; 98(2):653-61. PubMed ID: 2555017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Function and regulation of extracellular and intracellular receptors of platelet activating factor.
    Hwang SB
    Ann N Y Acad Sci; 1991; 629():217-26. PubMed ID: 1659279
    [No Abstract]   [Full Text] [Related]  

  • 20. Species-dependent differences of high affinity [3H]PAF-binding to platelets from humans and pigs and its inhibition by selected antagonists.
    Ostermann G; Lorenz A; Hofmann B; Kertscher HP
    J Lipid Mediat; 1991 Nov; 4(3):289-98. PubMed ID: 1662546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.